陈星宇,刘 爽,侯 雪,李嘉玮,阎雪莹

GE11是以高亲和力和选择性特异性结合EGFR受体的小分子多肽，其具有相对分子质量小、免疫原性低、易扩散及靶向性高等优势。此外，GE11缀合的纳米粒子增强药物在肿瘤中的蓄积等优点，使得其在生物医学领域，尤其是肿瘤的治疗等方面得到了较为广泛的应用。本文对GE11在癌症治疗中的应用进行总结，这些研究进展揭示了GE11肽在癌症治疗领域的巨大潜力。

GE11；抗肿瘤作用；表皮生长因子受体；药物靶向

[1] 李红侠,钱玉梅,徐礼生.Design, Synthesis and Anticancer Activity Evaluation of Novel Quinazoline Derivatives as EFGR Inhibitors[J].Chinese Journal of Structural Chemistry,2021,40(07):933-941.doi:10.14102/j.cnki.0254-5861.2011-3082. [2] 丁晓鹏,帖君,余嘉豪等.TACE联合抗血管生成药及PD-1抑制剂治疗中晚期肝癌的有效性和安全性[J].肝脏,2022,27(03):277-280+291. [3] de Miranda MC, Rodrigues MA, de Angelis Campos AC, Faria JAQA, Kunrath-Lima M, Mignery GA, Schechtman D, Goes AM, Nathanson MH, Gomes DA. Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase Cδ-4 (PLCδ4). J Biol Chem. 2019 Nov 8;294(45):16650-16662. doi: 10.1074/jbc.RA118.006961. Epub 2019 Sep 19. PMID: 31537645; PMCID: PMC6851314. [4] Goss G, Tsai CM, Shepherd FA, Bazhenova L, Lee JS, Chang GC, Crino L, Satouchi M, Chu Q, Hida T, Han JY, Juan O, Dunphy F, Nishio M, Kang JH, Majem M, Mann H, Cantarini M, Ghiorghiu S, Mitsudomi T. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2016 Dec;17(12):1643-1652. doi: 10.1016/S1470-2045(16)30508-3. Epub 2016 Oct 14. PMID: 27751847. [5] Wu X, Li Z, Yao M, Wang H, Qu S, Chen X, Li J, Sun Y, Xu Y, Gu J. Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy. Acta Biochim Biophys Sin (Shanghai). 2008 Mar;40(3):217-25. doi: 10.1111/j.1745-7270.2008.00389.x. PMID: 18330476.

点击下载PDF